IL-33 Has a Protective Effect Against Perinatal Listeriosis by Regulating Mitophagy of CD8 <sup>+</sup> T Lymphocytes
Listeriosis is a foodborne disease caused by <i>Listeria monocytogenes</i> (Lm) that usually leads to serious adverse outcomes in pregnant women. Interleukin (IL)-33/serum stimulation (ST)2 axis has an important impact on infectious diseases, but its role in listeriosis is rarely studied. Here, the immunomodulatory effects of IL-33/ST2 axis during perinatal Lm infection were investigated. In our study, the perinatal Lm infection model was constructed by injecting Lm into the tail vein of C57BL/6J mice. IL-33/ST2 axis was blocked by intraperitoneal injection of anti-IL-33Rα/ST2 antibody. <i>In vitro</i>, mouse cytotoxic T lymphocyte cell line (CTLL)-2 cells were activated by using CD3/CD28 antibodies. Perinatal Lm infection caused massive necrosis of liver tissue. Blocking IL-33/ST2 axis in pregnant mice inhibited the infiltration of CD8<sup>+</sup> T lymphocytes into the site of infection and further aggravated liver damage. We also found that IL-33 promotes mitochondrial autophagy in activated CTLL-2 cells <i>in vitro</i>. Mitochondrial autophagy was beneficial to the clearance of damaged mitochondria and reduced the production of reactive oxygen species. IL-33/ST2 axis affects the immune function of CD8<sup>+</sup> T lymphocytes by regulating mitophagy, which plays a very important role in the occurrence and development of perinatal Lm infection. Immunomodulation targeting IL-33/ST2 axis may be an effective way to adjuvant treatment of perinatal Lm infection.
Authors
- Hongliang Wu (ORCID: https://orcid.org/0000-0002-4621-6478)
- Chenghong Yin (ORCID: https://orcid.org/0000-0002-2503-3285)
- Yuxi Yang
- Yingyi Luan (ORCID: https://orcid.org/0000-0002-6986-1701)
- Fei Chen (ORCID: https://orcid.org/0000-0002-5819-1490)
- Tingjuan Shi (ORCID: https://orcid.org/0000-0003-0486-6699)
- Yingying Li (ORCID: https://orcid.org/0000-0003-1184-9475)
- Tian Xia (ORCID: https://orcid.org/0000-0003-4477-756X)
- Ning Xu (ORCID: https://orcid.org/0000-0002-6064-329X)
Institutions
- Capital Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Beijing Obstetrics and Gynecology Hospital (CN)
Publication Details
- Journal
- Journal of Interferon & Cytokine Research
- Published
- 2025-06-13
- DOI
- https://doi.org/10.1089/jir.2025.0069
- Primary Topic
- IL-33, ST2, and ILC Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00